Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer

Anticancer Research

Volumn 29, Issue 2, 2009, Pages 641-645

  Kuemmel, Sherko ^a   Thomas, Anke ^b   Landt, Solveig ^a   Fuger, Andrea ^b   Schmid, Peter ^c   Kriner, Monika ^d   Blohmer, Jens Uwe ^e   Sehouli, Jalid ^b   Schaller, Gerhard ^f   Lichtenegger, Werner ^b   Köninger, Angela ^a   Fuchs, Ilka ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Department of Gynecology and Obstetrics   (Germany)

^f Breast Care Unit   (Germany)

Author keywords

Cervical carcinoma; Disease progression; Soluble VEGF members; Soluble VEGF receptors; Tumor markers; Vascular endothelial growth factor

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; SOLUBILITY; UTERINE CERVIX CANCER;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 61449097778     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K and Eriksson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 3: 2576-2581, 1996.
2. Wang TB, Deng MH, Qiu WS and Dong WG: Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer. World J Gastroenterol 13: 1794-1798, 2007.
3. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V and Alitalo K: VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829-3837, 1996.
4. Cheng WF, Chen CA, Lee CN, Wei LH, Hsieh FJ and Hsieh CY: Vascular endothelial growth factor and prognosis of cervical carcinoma. Obstet Gynecol 96: 721-726, 2000.
5. Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K and Watanabe G: Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. J Thorac Cardiovasc Surg 128: 517-522, 2004.
6. Dai Y, Zhang X, Peng Y and Wang Z: The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma. Gynecol Oncol 97: 96-103, 2005.
7. Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE and Kohli M: Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease. Clin Cancer Res 11: 584-593, 2005.
8. Hanrahan V, Currie MJ, Gunningham SP Morrin HR, Scott PA, Robinson BA and Fox SB: The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol 200: 183-194, 2003.
9. Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K and Sekiya S: Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 103: 724-730, 2005.
10. Obermair A, Bancher-Todesca D, Bilgi S, Kaider A, Kohlberger P, Müllauer-Ertl S, Leodolter S and Gitsch G: Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst 89: 1212-1217, 1997.
11. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T and Tominaga T: Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826, 1996.
12. Kuemmel S, Eggemann H, Luftner D, Thomas A, Jeschke S, Zerfel N, Heilmann V, Emons G, Zeiser T, Ulm K, Kobl M, Korlach S, Schmid P, Sehouli J, Elling D and Blohmer JU: Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes. Anticancer Res 26: 1719-1726, 2006.
13. Hoar FJ, Lip GY, Belgore F and Stonelake PS: Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer. Int J Biol Markers 19: 229-235, 2004.
14. Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ and Sood AK: Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res 8: 3193-197, 2002.
15. Duff SE, Saunders M, McCredie V, Kumar S, O'Dwyer ST and Jayson GC: Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer. Clin Oncol (R Coll Radiol) 17: 367-371, 2005.
16. Lebrecht A, Ludwig E, Huber A, Klein M, Schneeberger C, Tempfer C, Koelbl H and Hefler L: Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer. Gynecol Oncol 85: 32-35, 2002.
17. Hashimoto I, Kodama J, Seki N, Kongo A, Yoshinouchi M, Okuda H and Kudo T: Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br J Cancer 85: 93-97, 2001.
18. Thelen A, Scholz A, Benckert C, von Marschall Z, Schröder M, Wiedenmann B, Neuhaus P, Rosewicz S and Jonas S: VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. Int J Cancer 122: 2471-2481, 2008.
19. Wong SY, Haack H, Crowley D, Barry M, Bronson RT and Hynes RO: Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 65: 9789-9798, 2005.
20. Mathur SP, Mathur RS, Gray EA, Lane D, Underwood PG, Kohler M and Creasman WT: Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected] Gynecol Oncol 98: 467-483, 2005. Erratum in: Gynecol Oncol 101: 186, 2006.
21. Lane D, Gray EA, Mathur RS and Mathur SP: Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Am J Reprod Immunol 53: 153-158, 2005.
22. Juttner S, Wissmann C, Jons T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W and Höcker M: Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 24: 228-240, 2006.
23. Van Trappen PO, Steele D, Lowe DG, Baithun S, Beasley N, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper MS, Jackson DG, Sleeman JP and Jacobs IJ: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 201: 544-554, 2003.
24. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y and Hirohashi S: Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 6: 2431-2439, 2000.
25. Kopfstein L, Veikkola T, Djonov VG, Baeriswyl V, Schomber T, Strittmatter K, Stacker SA, Achen MG, Alitalo K and Christofori G: Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am J Pathol 170: 1348-1361, 2007.
26. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39: 469-478, 2006.
27. Hiratsuka S, Maru Y, Okada A, Seiki M, Noda T and Shibuya M: Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res 61: 1207-1213, 2001.
28. Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis 9: 225-230, 2006; discussion 231.
29. Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, Steiner P, Hicklin D, Persaud K, Tonra JR, Witte L and Alitalo K: Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res 67: 593-599, 2007.
30. Bachtiary B, Selzer E, Knocke TH, Potter R and Obermair A: Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. Cancer Lett 179: 197-203, 2002.